Drug maker launches NAFTA suit
Published by Steve Coleman on March 15, 2012
Generic drug maker Apotex has launched a free trade complaint against the US government over a 2009 "import alert" issued over medications launched at two Toronto plants.
The company says it wants at least $520 million in compensation for an alleged violation of three NAFTA articles over the way it was treated.
See the following Globe & Mail story for more.
Found in: news